ReviewPolymers2025
Urushiol-Based Antimicrobial Coatings: Molecular Mechanisms, Structural Innovations, and Multifunctional Applications.
Review in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Toward In Situ Stabilization of Raw Chinese Lacquer (Polymers · 2026Review
- Article
- Advances in antibiofilm strategies for medical implant-associated infections: emerging technologies and translational challenges.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urushiol, the principal bioactive component of natural lacquer, has emerged as a promising candidate for developing eco-friendly antimicrobial coatings due to its unique catechol structure and long alkyl chains. This review systematically elucidates the molecular mechanisms underpinning urushiol's broad-spectrum antimicrobial activity, including membrane disruption via hydrophobic interactions, oxidative stress induction through redox-active phenolic groups, and enzyme inhibition via hydrogen bonding. Recent advances in urushiol-based composite systems-such as metal coordination networks, organic-inorganic hybrids, and stimuli-responsive platforms-are critically analyzed, highlighting their enhanced antibacterial performance, environmental durability, and self-healing capabilities. Case studies demonstrate that urushiol derivatives achieve >99% inhibition against both Gram-positive and Gram-negative pathogens, outperforming conventional agents like silver ions and quaternary ammonium salts. Despite progress, challenges persist in balancing antimicrobial efficacy, mechanical stability, and biosafety for real-world applications. Future research directions emphasize precision molecular engineering, synergistic multi-target strategies, and lifecycle toxicity assessments to advance urushiol coatings in medical devices, marine antifouling, and antiviral surfaces. This work provides a comprehensive framework for harnessing natural phenolic compounds in next-generation sustainable antimicrobial materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.